
International health officials announced that measles no longer holds eliminated status in the United States, a development that was anticipated but carries significant implications. The determination reflects transmission that has already taken place and represents a setback in the nation’s public health achievements. The finding has sparked political controversy, with opposition figures criticizing the current administration and the health secretary for inadequate response to recent outbreaks and inconsistent messaging regarding vaccine benefits.
The Trump administration withdrew its nomination of Heidi Overton to lead the Food and Drug Administration following concerns about her lack of sufficient Republican support in the Senate health panel. Overton, a preventive care physician with prior White House experience, would have faced a scheduled confirmation vote this week.
Meanwhile, STAT’s essay series examining potential medical school redesign continues with a proposal for a centralized digital curriculum model. An M.D./Ph.D. student outlined a system where candidates meeting baseline requirements like MCAT scores could enroll in a standardized pre-clerkship program before transitioning to hands-on clinical training, questioning whether all components of medical education must remain institutionally bundled.
According to the March of Dimes annual report, only a limited number of states have achieved the Healthy People 2030 target for preterm birth rates. The national average preterm birth rate remained at 10.4% for the fourth consecutive year, exceeding the target goal of 9.4%. Additionally, 16 states met the infant mortality target of 5 deaths per 1,000 births, though disparities persist with Black infants experiencing rates approximately twice the national average.
Senate appropriators released a fiscal year 2027 funding bill for the Department of Health and Human Services that allocated an additional $500 million to National Institutes of Health research compared to current levels. However, the bill provided no dedicated new funding for myalgic encephalomyelitis/chronic fatigue syndrome research, despite advocates requesting $50 million. The NIH currently allocates $13 million annually to ME/CFS research.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI